Clark AJ - Search Results

1

Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene.

Woods KA, Camacho-Hübner C, Savage MO, Clark AJ. Woods KA, et al. Among authors: clark aj. N Engl J Med. 1996 Oct 31;335(18):1363-7. doi: 10.1056/NEJM199610313351805. N Engl J Med. 1996. PMID: 8857020 Free article. No abstract available.

2

Insulin-like growth factor (IGF)-I gene deletion.

Camacho-Hübner C, Woods KA, Clark AJ, Savage MO. Camacho-Hübner C, et al. Among authors: clark aj. Rev Endocr Metab Disord. 2002 Dec;3(4):357-61. doi: 10.1023/a:1020957809082. Rev Endocr Metab Disord. 2002. PMID: 12424437 Review. No abstract available.

3

Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: effects of rhIGF-I therapy.

Camacho-Hübner C, Woods KA, Miraki-Moud F, Clark A, Savage MO. Camacho-Hübner C, et al. Growth Horm IGF Res. 1999 Jun;9 Suppl B:47-51; discussion 51-2. doi: 10.1016/s1096-6374(99)80081-1. Growth Horm IGF Res. 1999. PMID: 10549306

4

Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.

Camacho-Hübner C, Woods KA, Miraki-Moud F, Hindmarsh PC, Clark AJ, Hansson Y, Johnston A, Baxter RC, Savage MO. Camacho-Hübner C, et al. Among authors: clark aj. J Clin Endocrinol Metab. 1999 May;84(5):1611-6. doi: 10.1210/jcem.84.5.5649. J Clin Endocrinol Metab. 1999. PMID: 10323388

5

Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion.

Woods KA, Camacho-Hübner C, Bergman RN, Barter D, Clark AJ, Savage MO. Woods KA, et al. Among authors: clark aj. J Clin Endocrinol Metab. 2000 Apr;85(4):1407-11. doi: 10.1210/jcem.85.4.6495. J Clin Endocrinol Metab. 2000. PMID: 10770174

6

Diagnostic and therapeutic advances in growth hormone insensitivity.

David A, Metherell LA, Clark AJ, Camacho-Hübner C, Savage MO. David A, et al. Among authors: clark aj. Endocrinol Metab Clin North Am. 2005 Sep;34(3):581-95, viii. doi: 10.1016/j.ecl.2005.04.009. Endocrinol Metab Clin North Am. 2005. PMID: 16085161 Review.

7

Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.

Savage MO, Attie KM, David A, Metherell LA, Clark AJ, Camacho-Hübner C. Savage MO, et al. Among authors: clark aj. Nat Clin Pract Endocrinol Metab. 2006 Jul;2(7):395-407. doi: 10.1038/ncpendmet0195. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932322 Review.

8

Phenotypic aspects of growth hormone- and IGF-I-resistant syndromes.

Savage MO, David A, Camacho-Hubner C, Metherell LA, Clark AJ. Savage MO, et al. Among authors: clark aj. Endocr Dev. 2009;14:143-50. doi: 10.1159/000207483. Epub 2009 Feb 27. Endocr Dev. 2009. PMID: 19293581 Review.

9

Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity.

David A, Hwa V, Metherell LA, Netchine I, Camacho-Hübner C, Clark AJ, Rosenfeld RG, Savage MO. David A, et al. Among authors: clark aj. Endocr Rev. 2011 Aug;32(4):472-97. doi: 10.1210/er.2010-0023. Epub 2011 Apr 27. Endocr Rev. 2011. PMID: 21525302 Review.

10

Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity.

Bjarnason R, Banerjee K, Rose SJ, Rosberg S, Metherell L, Clark AJ, Albertsson-Wikland K, Savage MO. Bjarnason R, et al. Among authors: clark aj. Clin Endocrinol (Oxf). 2002 Sep;57(3):357-61. doi: 10.1046/j.1365-2265.2002.01607.x. Clin Endocrinol (Oxf). 2002. PMID: 12201828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

920 results

Search Page

Filters